News Digest — Monday 3 August 2026

Leslie Cui

03 Aug 2026 — 1 min read

USPTO foreign-applicant must be represented by a USPTO registered practioner
Effective July 20, 2026, foreign-domiciled applicants and owners must be represented by a registered practitioner. This representation requirement is part of the USPTO’s ongoing efforts to improve efficiency, reduce the backlog, improve quality, and deter fraud and misrepresentation in patent matters. It applies to every covered paper received on or after that date, for example, ADSs, amendments, IDSs, petitions, and micro-entity certifications, regardless of the application filing date.

Threshold of unintentional-delay petitions halved to one-year
For petitions filed on or after August 13, 2026, USPTO is requiring additional evidentiary support for proving unintentional delay more than one year after the missed deadline, a significant tightening of the threshold compared to the prior two-year standard.

CAFC reverses University of Texas patent victory against Boston Scientific
The court found University of Texas patent on Drug Releasing Biodegradable Fiber Implant invalid due to anticipation by a 1994 prior art reference (the Song patent) and ruled that Boston Scientific’s stent coatings do not infringe on the patent as not satisfying the patent’s fiber limitation for being not inherently thread-like.

Supreme Court Decision in Skinny-Label Induced Infringement

On June 4, 2026, Justice Jackson wrote for a unanimous Court reversing the Federal Circuit, holding Amarin failed to plausibly allege that Hikma actively induced infringement through its generic. NDA, ANDA, and “Skinny Labels” Pharmaceutical companies usually submit a new drug application (NDA) to the FDA with full data on

News Briefing: 10/27 - 10/31

10/27 – Kivu Raised $92 Million in Series A Kivu Biosciences, an antibody-drug conjugate biotech startup, has raised $92 million in a Series A funding.1 The company is working with the GlycoConnectTM technology from Synaffix that attaches its proprietary linker-payloads specifically to asparagine-297, a highly conserved native glycan around

News Briefing: 10/16 - 10/24

10/16 – Wave Achieves First-Ever RNA Editing in Human Wave Life Sciences announced positive proof-of-mechanism data from its ongoing phase 1a/2a study of GalNAc-conjugated RNA editing oligonucleotide (called WVE-006) in treating alpha-1 antitrypsin deficiency (AATD).1 The oligonucleotide recruits the Adenosine deaminases acting on RNA (ADAR) to correct a

News Briefing: 10/10-10/15

10/10 – Nobel Prize in Chemistry Nobel Prize in Chemistry 2024 has been awarded to David Baker “for computational protein design” and Demis Hassabis and John M. Jumper “for protein structure prediction”.1 David Baker developed algorithm called Rosetta for de novo protein structure design that results in the creation

Read more

Supreme Court Decision in Skinny-Label Induced Infringement

News Briefing: 10/27 - 10/31

News Briefing: 10/16 - 10/24

News Briefing: 10/10-10/15